# Roivant Sciences Ltd.: Form 8-K, filed Sep 18, 2026

- Company: [Roivant Sciences Ltd.](/companies/roiv.md) (CIK 1635088)
- Form: 8-K
- Filed: 2026-09-18
- Accepted by EDGAR: Sep 18, 2026, 07:14 ET
- Period: 2026-09-16
- Accession: 0001635088-26-000095
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1635088/000163508826000095/roiv-20260916.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1635088/000163508826000095/

## Items reported

- Item 5.07: Shareholder vote results
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1635088/000163508826000095/roiv-20260916.htm

Filed Sep 18, 2026.
Source: SEC EDGAR, the filing index for accession 0001635088-26-000095. Last ingested by Listed: Nov 15, 2026, 00:46 ET. No prices; not investment advice.
